Walter Eisner • Thu, July 20th, 2017 Medtronic plc says it has reached an agreement with “substantially all” remaining claimants involving the Infuse bone graft product. In a June 27, 2017 10K filing with the SEC, the company announced the agreements with approximately 6,000 claimants. The company also said it […]